- Published at
- by investing.com
positive
positive
Merck stock rises following Hansoh Pharma deal By Investing.com
Merck stock rises following Hansoh Pharma deal
News for Hansoh Pharmaceutical Group Company Limited (3692.HK)
- Published at
- by investing.com
positivepositiveSilence Therapeutics shares start at Buy from Jefferies, reflecting strong clinical data By Investing.com
Silence Therapeutics shares start at Buy from Jefferies, reflecting strong clinical data- Published at
- by investing.com
mixedmixedSilence Therapeutics receives $2 million from Hansoh Pharma By Investing.com
Silence Therapeutics receives $2 million from Hansoh Pharma- Published at
- by globenewswire.com
mixedmixedPulmonary Arterial Hypertension Market To Reach USD 12.2 Billion By 2032 | DataHorizzon Research
The pulmonary arterial hypertension market size was valued at USD 7.5 Billion in 2023 and is expected to reach a market size of USD 12.2 Billion by 2032 at...- Published at
- by insidermonkey.com
mixedmixed25 Richest Billionaires in Healthcare Industry
In this article, we discuss the 25 richest billionaires in healthcare industry.- Published at
- by globenewswire.com
positivepositiveSCYNEXIS Reports Third Quarter 2023 Financial Results and Provides Corporate Update
IND enabling development activities for SCY-247, the next generation fungerp from SCYNEXIS’ proprietary antifungal platform, continue to advanceRemediation...- Published at
- by globenewswire.com
positivepositiveSCYNEXIS Reports Second Quarter 2023 Financial Results and Provides Corporate Update
SCYNEXIS reported the closing of an exclusive license agreement with GSK for BREXAFEMME® (Ibrexafungerp Tablets). SCYNEXIS received an upfront payment of...- Published at
- by prnewswire.com
positivepositiveAntengene Enters into Commercialization Partnership with Hansoh Pharma for First/Only-in-Class XPO1 Inhibitor XPOVIO®(selinexor) in the Mainland of China
- Antengene and Hansoh Pharma to enter into collaboration agreement involving commercialization of XPOVIO® in the mainland of China, broadening coverage and...- Published at
- by marketscreener.com
mixedmixed- Published at
- by financialpost.com
neutralneutralBiocytogen and Hansoh Pharma Announce an Antibody License Agreement
BEIJING & SHANGHAI — Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, SEHK : 02315) a clinical-stage biotechnology company with a focus on the…- Published at
- by globenewswire.com
mixedmixedRich Insights into the Knee Osteoarthritis Clinical Trial Analysis Featuring 60+ Companies and Therapies | DelveInsight
The prevalence of Knee Osteoarthritis has been rising since the past few years, which prompts the growing demand for the treatment options. The market is...